F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: A Cancer Journal for Clinicians, vol.68, issue.6, pp.394-424, 2018.

F. Bray, M. Colombet, L. Mery, M. Piñeros, A. Znaor et al., Lyon: International Agency for Research on Cancer, Cancer Incidence in Five Continents, vol.XI, 2017.

F. Malekzadeh, A. Gandomkar, Z. Malekzadeh, H. Poustchi, M. Moghadami et al., Effectiveness of Polypill for Prevention of Cardiovascular Disease (PolyPars): Protocol of a Randomized Controlled Trial, Archives of Iranian Medicine, vol.23, issue.8, pp.548-556, 2020.

, Occupational exposures in insecticide application, and some pesticides, Cancer Causes and Control, vol.3, issue.4, pp.398-398, 1992.

P. Correa, W. Haenszel, C. Cuello, S. Tannenbaum, and M. Archer, A model for gastric cancer epidemiology. The Lancet, vol.306, pp.58-60, 1975.

M. Plummer, C. De-martel, J. Vignat, J. Ferlay, F. Bray et al., Global burden of cancers attributable to infections in 2012: a synthetic analysis, Lancet Glob Health, vol.4, issue.9, pp.30143-30150, 2016.

J. K. Hooi, W. Y. Lai, W. K. Ng, M. M. Suen, F. E. Underwood et al., Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis, Gastroenterology, vol.153, issue.2, pp.420-429, 2017.

M. Inoue, Changing epidemiology of Helicobacter pylori in Japan, Gastric Cancer, vol.20, issue.S1, pp.3-7, 2016.

S. H. Lim, N. Kim, J. W. Kwon, S. E. Kim, G. H. Baik et al., Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: A cross-sectional nationwide multicenter study, PLOS ONE, vol.13, issue.10, p.e0204762, 2018.

D. Maucort-boulch, S. Franceschi, and M. Plummer, International Correlation between Human Papillomavirus Prevalence and Cervical Cancer Incidence, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.3, pp.717-720, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00428135

R. Newton, J. L. Ziegler, D. Casabonne, L. Carpenter, B. D. Gold et al., Helicobacter pylori and cancer among adults in Uganda, Infectious Agents and Cancer, vol.1, issue.1, p.17150134, 2006.

N. Kodaman, A. Pazos, B. G. Schneider, M. B. Piazuelo, R. Mera et al., Human and Helicobacter pylori coevolution shapes the risk of gastric disease, Proceedings of the National Academy of Sciences, 2014.

J. Torres, P. Correa, C. Ferreccio, G. Hernandez-suarez, R. Herrero et al., Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America, Cancer Causes & Control, vol.24, issue.2, pp.249-256, 2012.

J. G. Fox and T. C. Wang, Inflammation, atrophy, and gastric cancer, Journal of Clinical Investigation, vol.117, issue.1, pp.60-69, 2007.

M. A. Adamu, M. N. Weck, D. Rothenbacher, and H. Brenner, Incidence and risk factors for the development of chronic atrophic gastritis: Five year follow-up of a population-based cohort study, International Journal of Cancer, vol.128, issue.7, pp.1652-1658, 2010.

. Eurohepygast-study-group, Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study, Gut, vol.50, issue.6, pp.779-785, 2002.

S. Oh, N. Kim, H. Yoon, Y. J. Choi, J. Y. Lee et al., Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in First-Degree Relatives of Gastric Cancer Patients Compared with Age-Sex Matched Controls, Journal of Cancer Prevention, vol.18, issue.2, pp.149-160, 2013.

M. Leja, M. C. Camargo, I. Polaka, S. Isajevs, I. Liepniece-karele et al., Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays, Helicobacter, vol.22, issue.4, p.e12393, 2017.

M. Segi, Cancer Mortality for Selected Sites in 24 Countries, pp.1950-57, 1960.

J. Frank, M. Sergio, T. Svetlozar, and G. A. Bala, Appendix E: Model Selection Criterion: AIC and BIC, The Basics of Financial Econometrics, pp.399-403, 2014.

A. M. Ekström, M. Held, L. E. Hansson, L. Engstrand, and O. Nyrén, Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection, Gastroenterology, vol.121, issue.4, pp.784-791, 2001.

C. Holcombe, Helicobacter pylori: the African enigma., Gut, vol.33, issue.4, pp.429-431, 1992.

S. A. Con, A. L. Valerín, H. Takeuchi, R. Con-wong, V. G. Con-chin et al., Helicobacter pylori CagA status associated with gastric cancer incidence rate variability in Costa Rican regions, Journal of Gastroenterology, vol.41, issue.7, pp.632-637, 2006.

K. Singh and U. C. Ghoshal, Causal role of Helicobacter pylori infection in gastric cancer: An Asian enigma, World Journal of Gastroenterology, vol.12, issue.9, p.1346, 2006.

D. Y. Graham, H. Lu, and Y. Yamaoka, African, Asian or Indian enigma, the East AsianHelicobacter pylori: facts or medical myths, Journal of Digestive Diseases, vol.10, issue.2, pp.77-84, 2009.

I. Kato, J. Vivas, M. Plummer, G. Lopez, S. Peraza et al., Environmental Factors in Helicobacter pylori-Related Gastric Precancerous Lesions in Venezuela, Cancer Epidemiology Biomarkers & Prevention, vol.13, issue.3, pp.468-76, 2004.

M. Feldman, B. Cryer, E. Lee, and W. L. Peterson, Role of Seroconversion in Confirming Cure of <EMPH TYPE="ITAL">Helicobacter pylori</EMPH> Infection, JAMA, vol.280, issue.4, p.363, 1998.

J. Q. Huang, G. F. Zheng, K. Sumanac, E. J. Irvine, and R. H. Hunt, Meta-analysis of the relationship between cagA seropositivity and gastric cancer, Gastroenterology, vol.125, issue.6, pp.1636-1680, 2003.

G. Murphy, N. D. Freedman, A. Michel, J. Fan, P. R. Taylor et al., Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort, International Journal of Cancer, vol.137, issue.8, pp.1938-1984, 2015.

S. M. Devi, I. Ahmed, P. Francalacci, M. A. Hussain, Y. Akhter et al., Ancestral European roots of Helicobacter pylori in India, BMC Genomics, vol.8, issue.1, p.184, 2007.

M. C. Camargo, M. Beltran, C. J. Conde-glez, P. R. Harris, A. Michel et al., Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer, International journal of cancer, vol.137, issue.12, p.26178251, 2015.

E. Nacional-de-salud, Tomo 2. Resultatos. [National Health Survey, vol.2, p.10, 2009.

L. López-carrillo, M. López-cervantes, G. Robles-díaz, A. Ramírez-espitia, A. Mohar-betancourt et al., Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico, International Journal of Cancer, vol.106, issue.2, pp.277-282, 2003.

M. N. Satyanarayana, Capsaicin and Gastric Ulcers, Critical Reviews in Food Science and Nutrition, vol.46, issue.4, pp.275-328, 2006.

L. Ló-pez-carrillo, M. C. Camargo, B. G. Schneider, L. A. Sicinschi, R. U. Herná-ndez-ramírez et al., Capsaicin consumption, Helicobacter pylori CagA status and IL1B-31C>T genotypes: a host and environment interaction in gastric cancer, Food Chem Toxicol, vol.50, issue.6, pp.2118-2140, 2012.

L. Nogueira, C. Foerster, and J. Groopman, Association of aflatoxin with gallbladder cancer in chile, JAMA, vol.313, issue.20, pp.2075-2082, 2015.

, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A review of human carcinogens, vol.100, 2012.

S. Eom, D. Yim, Y. Zhang, J. Yun, S. I. Moon et al., Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean, Cancer Causes & Control, vol.24, issue.11, p.23949201, 2013.

K. Khaw, S. Bingham, A. Welch, R. Luben, E. O&apos;brien et al., Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk), The American Journal of Clinical Nutrition, vol.80, issue.5, pp.1397-403, 2004.

M. Dinis-ribeiro, G. Yamaki, K. Miki, A. Costa-pereira, M. Matsukawa et al., Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening, J Med Screen, vol.11, issue.3, pp.141-148, 2004.

D. Palli, G. Masala, D. Giudice, G. Plebani, M. Basso et al., CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study, International Journal of Cancer, vol.120, issue.4, pp.859-67, 2007.